Injectable quinolone formulations

Details Injectable quinolone formulations Injectable quinolone formulations

A - Human Necessities

61

K

A61K 31/47 (2006.01) A61K 9/08 (2006.01) A61K 31/4995 (2006.01) A61K 47/02 (2006.01) A61K 47/22 (2006.01)

Patent

CA 2239352

Aqueous pharmaceutical solutions suitable for injection into a host, having improved injection site toleration, comprise danofloxacin or its pharmaceutically acceptable salts and a magnesium or zinc compound. The zinc compound in addition requires the presence of a co-solvent.

Cette invention concerne des solutions pharmaceutiques aqueuses que l'on peut injecter à un sujet hôte et dont la tolérance au niveau du site d'injection est accrue. Ces solutions comportent de la danofloxacine, ou ses sels pharmaceutiquement acceptables, ainsi qu'un composé de magnésium ou de zinc. Le composé de zinc nécessite en outre la présence d'un co-solvant.

Affiliated with

Also associated with

Rating

Injectable quinolone formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Injectable quinolone formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable quinolone formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1857136